A machine-learning based objective measure for ALS disease severity.

Vieira, Fernando G; Venugopalan, Subhashini; Premasiri, Alan S; McNally, Maeve; Jansen, Aren; McCloskey, Kevin; Brenner, Michael P; Perrin, Steven

Vieira, Fernando G; Venugopalan, Subhashini; Premasiri, Alan S; McNally, Maeve; Jansen, Aren; McCloskey, Kevin; Brenner, Michael P; Perrin, Steven.

Afiliação

Vieira FG; ALS Therapy Development Institute, Watertown, MA, USA. fvieira@als.net.
Venugopalan S; Google Research, Google, Mountain View, CA, USA. vsubhashini@google.com.
Premasiri AS; ALS Therapy Development Institute, Watertown, MA, USA.
McNally M; ALS Therapy Development Institute, Watertown, MA, USA.
Jansen A; Google Research, Google, Mountain View, CA, USA.
McCloskey K; Google Research, Google, Mountain View, CA, USA.
Brenner MP; Google Research, Google, Mountain View, CA, USA.
Perrin S; School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.

NPJ Digit Med ; 5(1): 45, 2022 Apr 08.

Article em En | MEDLINE | ID: mdl-35396385

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: NPJ Digit Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google